# Kyntra Bio (KYNB) — Earnings

KYNB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kynb/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $2.96 |
| EPS estimate | $2.96 |
| EPS surprise | +0.00% |
| Revenue surprise | −14.10% |
| Revenue | −$1.5M |
| Revenue estimate | −$1.3M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/921299/000119312526349183/kynb-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | $2.96 | $2.96 | 0.00% | — | — |
| Q1 2026 | May 11, 2026 | −$3.36 | −$3.76 | -12.07% | $1.6M | $3.7M |
| Q4 2025 | Mar 16, 2026 | −$3.89 | −$3.51 | 9.65% | $1.7M | $1.3M |
| Q3 2025 | Nov 10, 2025 | −$4.01 | $49.61 | 1338.08% | $2.4M | $1.1M |
| Q2 2025 | Aug 11, 2025 | −$2.30 | −$1.88 | 18.38% | $2.6M | $1.3M |
| Q1 2025 | May 12, 2025 | $0.75 | $1.25 | 66.67% | $1.6M | $2.7M |
| Q4 2024 | Mar 17, 2025 | −$3.50 | $4.50 | 228.57% | $24.9M | $3.1M |
| Q3 2024 | Nov 12, 2024 | −$7.66 | −$4.25 | 44.50% | $34.8M | $46.3M |
| Q2 2024 | Aug 6, 2024 | −$8.00 | −$4.00 | 50.00% | $34.7M | $50.6M |
| Q1 2024 | May 6, 2024 | −$10.45 | −$8.25 | 21.06% | $36.7M | $55.9M |
| Q4 2023 | Feb 26, 2024 | −$10.63 | −$14.25 | -34.12% | $38.9M | $27.1M |
| Q3 2023 | Nov 6, 2023 | −$17.03 | −$16.25 | 4.56% | $36.8M | $40.1M |
| Q2 2023 | Aug 7, 2023 | −$17.60 | −$22.50 | -27.86% | $34.7M | $44.3M |
| Q1 2023 | May 8, 2023 | −$18.83 | −$20.25 | -7.52% | $31.5M | $36.2M |
| Q4 2022 | Feb 27, 2023 | −$23.46 | −$17.50 | 25.40% | $24.0M | $34.4M |
| Q3 2022 | Nov 7, 2022 | −$20.25 | −$24.50 | -20.99% | $31.6M | $15.7M |
| Q2 2022 | Aug 8, 2022 | −$23.04 | −$19.50 | 15.37% | $36.2M | $29.8M |
| Q1 2022 | May 9, 2022 | −$20.79 | −$17.00 | 18.24% | $28.8M | $60.8M |
| Q4 2021 | Feb 28, 2022 | −$16.57 | −$36.25 | -118.75% | $47.7M | $16.5M |
| Q3 2021 | Nov 9, 2021 | −$0.18 | $13.50 | 7814.29% | $129.7M | $156.0M |

## Frequently Asked Questions

### When did Kyntra Bio (KYNB) last report earnings?

Kyntra Bio last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did KYNB beat earnings estimates?

Kyntra Bio reported EPS of $2.96 for Q2 2026, in line with the $2.96 consensus estimate.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).